Intrinsic Value of S&P & Nasdaq Contact Us

Invivyd, Inc. IVVD NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
60/100
4/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$9.50
+490.1%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Invivyd, Inc. (IVVD) has a negative trailing P/E of -5.1, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 10.2 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -19.52%, forward earnings yield 9.78%. PEG 0.06 (Peter Lynch undervalued ≤1.0).

Criteria proven by this page:

  • VALUE (100/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.06); analyst target implies upside (+490.1%).
  • Forward P/E 10.2 — analysts expect a return to profitability with estimated EPS of $0.16 for FY2029.
  • PEG Ratio 0.06 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield -19.52% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 9.78% as earnings recover.
  • Analyst consensus target $9.50 (+490.1% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 60/100 with 4/7 criteria passed.

SharesGrow 7-Criteria Score
60/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
64/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
46/100
→ Income
GROWTH
100/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — IVVD

Valuation Multiples
P/E (TTM)-5.1
Forward P/E10.2
PEG Ratio0.06
Forward PEG0.06
P/B Ratio1.11
P/S Ratio3.88
EV/EBITDA0.3
Per Share Data
EPS (TTM)$-0.30
Forward EPS (Est.)$0.16
Book Value / Share$1.40
Revenue / Share$0.31
FCF / Share$-0.34
Yields & Fair Value
Earnings Yield-19.52%
Forward Earnings Yield9.78%
Dividend Yield0.00%
Analyst Target$9.50 (+490.1%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2020 -20.7 0.00 -35.60 0.00 -
2021 -3.5 -0.01 1.44 0.00 -
2022 -0.7 -0.24 0.46 0.00 -
2023 -2.2 0.13 2.43 0.00 -
2024 -0.3 0.01 0.78 2.07 -
2025 -8.1 0.10 1.76 7.96 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2020 $-0.59 $0.00 $-65.32M -
2021 $-2.11 $0.00 $-234.29M -
2022 $-2.17 $0.00 $-234.6M -
2023 $-1.81 $0.00 $-198.64M -
2024 $-1.43 $25.38M $-169.93M -669.4%
2025 $-0.30 $53.43M $-52.49M -98.2%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-0.16 $-0.17 – $-0.14 $129.73M $86.4M – $217.81M 2
2027 $-0.18 $-0.34 – $-0.10 $159.24M $106.06M – $267.36M 2
2028 $0.06 $-0.65 – $0.69 $267.19M $177.96M – $448.61M 4
2029 $0.26 $0.15 – $0.48 $389.78M $259.61M – $654.43M 2
2030 $0.52 $0.29 – $0.97 $543.12M $361.74M – $911.89M 2
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message